BCL2 and acute myeloid leukemia: Moreover, treatment with etomoxir or orlistat sensitized these cell lines to apoptosis induction with ABT-737 (Bcl-xL, Bcl-2, and Bcl-w antagonist) and etomoxir also improved the efficacy of ABT-737 in a human AML murine model.